Drugs that contain Lisinopril
1. Qbrelis patents expiration
QBRELIS Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10265370 | AZURITY | Lisinopril formulations |
Nov, 2035
(11 years from now) | |
| US10940177 | AZURITY | Lisinopril formulations |
Nov, 2035
(11 years from now) | |
| US10039800 | AZURITY | Lisinopril formulations |
Nov, 2035
(11 years from now) | |
| US9616096 | AZURITY | Lisinopril formulations |
Nov, 2035
(11 years from now) | |
| US9463183 | AZURITY | Lisinopril formulations |
Nov, 2035
(11 years from now) | |
| US11179434 | AZURITY | Lisinopril formulations |
Nov, 2035
(11 years from now) | |
| US9814751 | AZURITY | Lisinopril formulations |
Nov, 2035
(11 years from now) | |
| US11771733 | AZURITY | Lisinopril formulations |
Nov, 2035
(11 years from now) | |
| US10406199 | AZURITY | Lisinopril formulations |
Nov, 2035
(11 years from now) | |
Market Authorisation Date: 29 July, 2016
Treatment: Method of treating hypertension; Method of treatment of heart failure; Acute myocardial infarction
Dosage: SOLUTION;ORAL
How can I launch a generic of QBRELIS before it's drug patent expiration?
More Information on Dosage
QBRELIS family patents
